The 1 analyst offering 1 year price forecasts for GX1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to GX1 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GX1 EPS for the last quarter is −0.23 EUR despite the estimation of −0.40 EUR. In the next quarter EPS is expected to reach −0.35 EUR. Track more of MARKER THERAPEUTICS INC financials and stay on top of what is up with the company.
According to analysts, GX1 price target is 17.49 EUR with a max estimate of 17.49 EUR and a min estimate of 17.49 EUR. Check if this forecast comes true in a year, meanwhile watch MARKER THERAPEUTICS INC stock price chart and keep track of the current situation with GX1 news and stock market news.